1. Home
  2. RDY vs ARCB Comparison

RDY vs ARCB Comparison

Compare RDY & ARCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RDY
  • ARCB
  • Stock Information
  • Founded
  • RDY 1984
  • ARCB 1923
  • Country
  • RDY India
  • ARCB United States
  • Employees
  • RDY N/A
  • ARCB N/A
  • Industry
  • RDY Biotechnology: Pharmaceutical Preparations
  • ARCB Trucking Freight/Courier Services
  • Sector
  • RDY Health Care
  • ARCB Industrials
  • Exchange
  • RDY Nasdaq
  • ARCB Nasdaq
  • Market Cap
  • RDY 2.1B
  • ARCB 1.9B
  • IPO Year
  • RDY N/A
  • ARCB N/A
  • Fundamental
  • Price
  • RDY $13.24
  • ARCB $63.96
  • Analyst Decision
  • RDY Buy
  • ARCB Buy
  • Analyst Count
  • RDY 1
  • ARCB 13
  • Target Price
  • RDY $17.00
  • ARCB $107.00
  • AVG Volume (30 Days)
  • RDY 1.9M
  • ARCB 299.7K
  • Earning Date
  • RDY 05-06-2025
  • ARCB 04-29-2025
  • Dividend Yield
  • RDY 3.61%
  • ARCB 0.75%
  • EPS Growth
  • RDY 2.68
  • ARCB N/A
  • EPS
  • RDY 0.75
  • ARCB 7.31
  • Revenue
  • RDY $3,637,607,642.00
  • ARCB $4,179,019,000.00
  • Revenue This Year
  • RDY $17.23
  • ARCB $4.57
  • Revenue Next Year
  • RDY $9.19
  • ARCB $7.28
  • P/E Ratio
  • RDY $17.94
  • ARCB $8.80
  • Revenue Growth
  • RDY 14.74
  • ARCB N/A
  • 52 Week Low
  • RDY $12.50
  • ARCB $63.51
  • 52 Week High
  • RDY $16.89
  • ARCB $153.60
  • Technical
  • Relative Strength Index (RSI)
  • RDY 48.34
  • ARCB 26.99
  • Support Level
  • RDY $13.09
  • ARCB $68.83
  • Resistance Level
  • RDY $13.85
  • ARCB $73.13
  • Average True Range (ATR)
  • RDY 0.14
  • ARCB 2.73
  • MACD
  • RDY 0.02
  • ARCB 0.11
  • Stochastic Oscillator
  • RDY 19.74
  • ARCB 3.45

About RDY Dr. Reddy's Laboratories Ltd

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

About ARCB ArcBest Corporation

ArcBest Corp is engaged in logistics operations. The company operates in two operating segments, The Asset-Based segment includes the results of operations of ABF Freight System, Inc. and certain other subsidiaries. The segment operations include national, inter-regional, and regional transportation of general commodities through standard, expedited, and guaranteed LTL services. The services including freight transportation related to managed transportation solutions and other services. The Asset-Light segment includes the results of operations of the Company's service offerings in truckload, ground expedite, dedicated, intermodal, household goods moving, managed transportation, warehousing and distribution, and international freight transportation for air, ocean, and ground.

Share on Social Networks: